|
| ID |
DDInter1767 |
| Drug Type |
small molecule |
| Molecular Formula |
C19H25N5O4 |
| Molecular Weight |
387.440
|
| Description |
Terazosin is an alpha-1 adrenergic antagonist used in the treatment of symptomatic benign prostatic hyperplasia and management of hypertension.
|
| ATC Classification |
G04CA03
|
| IUPAC Name |
6,7-Dimethoxy-2-[4-(Oxolane-2-Carbonyl)Piperazin-1-Yl]Quinazolin-4-Amine |
| InChI |
Inchi=1S/C19H25N5O4/C1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/H10-11,14H,3-9H2,1-2H3,(H2,20,21,22) |
| InChI Key |
VCKUSRYTPJJLNI-UHFFFAOYSA-N |
| Canonical SMILES |
COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|